The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Barton Shane | Principal Accounting Officer | Option exercise(M) | 4K | $10.85 | $47K |
| Jun 30, 2026 | Barton Shane | Principal Accounting Officer | Option exercise(M) | 4K | $8.39 | $34K |
| Jun 30, 2026 | Barton Shane | Principal Accounting Officer | Option exercise(M) | 4K | $4.30 | $17K |
| Jun 30, 2026 | Barton Shane | Principal Accounting Officer | Option exercise(M) | 8K | $4.38 | $34K |
| Jun 30, 2026 | Barton Shane | Principal Accounting Officer | Sell(S) | 20K | $25.19 | $509K |
| Jun 30, 2026 | Barton Shane | Principal Accounting Officer | Option exercise(M) | 4K | — | $0 |
| Jun 30, 2026 | Barton Shane | Principal Accounting Officer | Option exercise(M) | 4K | — | $0 |
| Jun 30, 2026 | Barton Shane | Principal Accounting Officer | Option exercise(M) | 4K | — | $0 |
| Jun 30, 2026 | Barton Shane | Principal Accounting Officer | Option exercise(M) | 8K | — | $0 |
| Jun 29, 2026 | Barton Shane | Principal Accounting Officer | Option exercise(M) | 9K | $10.85 | $101K |
| Jun 29, 2026 | Barton Shane | Principal Accounting Officer | Option exercise(M) | 7K | $8.39 | $61K |
| Jun 29, 2026 | Barton Shane | Principal Accounting Officer | Option exercise(M) | 9K | $4.30 | $39K |
| Jun 29, 2026 | Barton Shane | Principal Accounting Officer | Option exercise(M) | 14K | $4.38 | $62K |
| Jun 29, 2026 | Barton Shane | Principal Accounting Officer | Sell(S) | 42K | $25.21 | $1.1M |
| Jun 29, 2026 | Barton Shane | Principal Accounting Officer | Option exercise(M) | 9K | — | $0 |
| Jun 29, 2026 | Barton Shane | Principal Accounting Officer | Option exercise(M) | 7K | — | $0 |
| Jun 29, 2026 | Barton Shane | Principal Accounting Officer | Option exercise(M) | 9K | — | $0 |
| Jun 29, 2026 | Barton Shane | Principal Accounting Officer | Option exercise(M) | 14K | — | $0 |
| Jun 10, 2026 | Hemrajani Rekha | Director | Grant(A) | 22K | — | $0 |
| Jun 10, 2026 | Garnier Jean Pierre | Director | Grant(A) | 22K | — | $0 |
| Jun 10, 2026 | Pande Vijay Satyanand | Director | Grant(A) | 22K | — | $0 |
| Jun 10, 2026 | Enright Patrick G | Director | Grant(A) | 22K | — | $0 |
| Jun 10, 2026 | Davidson Michael H. | Director | Grant(A) | 22K | — | $0 |
| Jun 10, 2026 | Healy James | Director | Grant(A) | 22K | — | $0 |
| Apr 23, 2026 | Goldstein Dov A MD | Chief Financial Officer | Option exercise(M) | 4K | $4.38 | $16K |
| Apr 23, 2026 | Goldstein Dov A MD | Chief Financial Officer | Option exercise(M) | 4K | — | $0 |
| Apr 1, 2026 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 5K | $4.11 | $22K |
| Apr 1, 2026 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 3K | $6.57 | $22K |
| Apr 1, 2026 | Rubin Paul D | Chief Medical Officer | Sell(S) | 9K | $17.81 | $157K |
| Apr 1, 2026 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 5K | — | $0 |
| Apr 1, 2026 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 3K | — | $0 |
| Mar 2, 2026 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 2K | $6.57 | $13K |
| Mar 2, 2026 | Rubin Paul D | Chief Medical Officer | Sell(S) | 7K | $20.30 | $151K |
| Mar 2, 2026 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 5K | $4.11 | $22K |
| Mar 2, 2026 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 5K | — | $0 |
| Mar 2, 2026 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 2K | — | $0 |
| Mar 1, 2026 | Goldstein Dov A MD | Chief Financial Officer | Option exercise(M) | 4K | $4.38 | $16K |
| Mar 1, 2026 | Goldstein Dov A MD | Chief Financial Officer | Option exercise(M) | 4K | — | $0 |
| Feb 17, 2026 | Goldstein Dov A MD | Chief Financial Officer | Grant(A) | 110K | — | $0 |
| Feb 17, 2026 | Rubin Paul D | Chief Medical Officer | Grant(A) | 110K | — | $0 |
| Feb 17, 2026 | Fortney Kristen | Chief Executive Officer, Director | Grant(A) | 330K | — | $0 |
| Feb 17, 2026 | Barton Shane | Principal Accounting Officer | Grant(A) | 45K | — | $0 |
| Feb 17, 2026 | Morgen Eric | Chief Operating Officer, Director | Grant(A) | 13K | — | $0 |
| Feb 17, 2026 | Morgen Eric | Chief Operating Officer, Director | Grant(A) | 110K | — | $0 |
| Feb 2, 2026 | Rubin Paul D | Chief Medical Officer | Sell(S) | 7K | $18.75 | $139K |
| Feb 2, 2026 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 2K | $6.57 | $13K |
| Feb 2, 2026 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 5K | $4.11 | $22K |
| Feb 2, 2026 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 5K | — | $0 |
| Feb 2, 2026 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 2K | — | $0 |
| Feb 1, 2026 | Goldstein Dov A MD | Chief Financial Officer | Option exercise(M) | 4K | $4.38 | $16K |
| Feb 1, 2026 | Goldstein Dov A MD | Chief Financial Officer | Option exercise(M) | 4K | — | $0 |
| Jan 16, 2026 | Goldstein Dov A MD | Chief Financial Officer | Option exercise(M) | 4K | $4.38 | $16K |
| Jan 16, 2026 | Goldstein Dov A MD | Chief Financial Officer | Option exercise(M) | 4K | — | $0 |
| Jan 13, 2026 | Goldstein Dov A MD | Chief Financial Officer | Sell(S) | 4K | $19.45 | $86K |
| Jan 13, 2026 | Goldstein Dov A MD | Chief Financial Officer | Sell(S) | 12K | $20.54 | $240K |
| Jan 13, 2026 | Goldstein Dov A MD | Chief Financial Officer | Sell(S) | 2K | $21.08 | $41K |
| Jan 13, 2026 | Goldstein Dov A MD | Chief Financial Officer | Sell(S) | 9K | $18.43 | $165K |
| Jan 13, 2026 | Goldstein Dov A MD | Chief Financial Officer | Option exercise(M) | 27K | $8.39 | $227K |
| Jan 13, 2026 | Goldstein Dov A MD | Chief Financial Officer | Option exercise(M) | 27K | — | $0 |
| Jan 13, 2026 | Fortney Kristen | Chief Executive Officer, Director | Sell(S) | 233K | $18.12 | $4.2M |
| Jan 2, 2026 | Rubin Paul D | Chief Medical Officer | Sell(S) | 7K | $12.85 | $96K |
| Jan 2, 2026 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 2K | $6.57 | $13K |
| Jan 2, 2026 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 5K | $4.11 | $22K |
| Jan 2, 2026 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 5K | — | $0 |
| Jan 2, 2026 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 2K | — | $0 |
| Dec 9, 2025 | Rubin Paul D | Chief Medical Officer | Sell(S) | 18K | $12.00 | $216K |
| Dec 9, 2025 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 18K | $6.57 | $118K |
| Dec 9, 2025 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 18K | — | $0 |
| Dec 4, 2025 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 69K | $4.11 | $283K |
| Dec 4, 2025 | Rubin Paul D | Chief Medical Officer | Sell(S) | 69K | $10.19 | $702K |
| Dec 4, 2025 | Rubin Paul D | Chief Medical Officer | Option exercise(M) | 69K | — | $0 |
| Aug 7, 2025 | Pande Vijay Satyanand | Director | Grant(A) | 22K | — | $0 |
| Jun 5, 2025 | Garnier Jean Pierre | Director | Grant(A) | 22K | — | $0 |
| Jun 5, 2025 | Davidson Michael H. | Director | Grant(A) | 22K | — | $0 |
| Jun 5, 2025 | Enright Patrick G | Director | Grant(A) | 22K | — | $0 |
| Jun 5, 2025 | Healy James | Director | Grant(A) | 22K | — | $0 |
| Jun 5, 2025 | Hemrajani Rekha | Director | Grant(A) | 22K | — | $0 |
| Feb 18, 2025 | Barton Shane | Principal Accounting Officer | Grant(A) | 90K | — | $0 |
| Feb 18, 2025 | Fortney Kristen | Chief Executive Officer, Director | Grant(A) | 530K | — | $0 |
| Feb 18, 2025 | Goldstein Dov A MD | Chief Financial Officer | Grant(A) | 170K | — | $0 |
| Feb 18, 2025 | Rubin Paul D | Chief Medical Officer | Grant(A) | 200K | — | $0 |
| Feb 18, 2025 | Morgen Eric | Chief Operating Officer, Director | Grant(A) | 25K | — | $0 |
| Dec 18, 2024 | Barton Shane | Principal Accounting Officer | Grant(A) | 40K | — | $0 |
| Oct 3, 2024 | Pande Vijay Satyanand | Director | Buy(P) | 25K | $19.90 | $504K |
| Oct 2, 2024 | Pande Vijay Satyanand | Director | Buy(P) | 67K | $19.73 | $1.3M |
| Oct 1, 2024 | Pande Vijay Satyanand | Director | Buy(P) | 127K | $19.73 | $2.5M |
| Sep 27, 2024 | Barton Shane | Principal Accounting Officer | Buy(P) | 3K | $18.00 | $47K |
| Sep 27, 2024 | Hemrajani Rekha | Director | Buy(P) | 3K | $18.00 | $54K |
| Sep 27, 2024 | Chen Bihua | Insider | Buy(P) | 450K | $18.00 | $8.1M |
| Sep 27, 2024 | Chen Bihua | Insider | Conversion(C) | 1.2M | — | — |
| Sep 27, 2024 | Chen Bihua | Insider | Conversion(C) | 5.3M | — | — |
| Sep 27, 2024 | Healy James | Director | Conversion(C) | 1.6M | — | — |
| Sep 27, 2024 | Healy James | Director | Buy(P) | 589K | $18.00 | $10.6M |
| Sep 27, 2024 | Healy James | Director | Buy(P) | 26K | $18.00 | $477K |
| Sep 27, 2024 | Healy James | Director | Buy(P) | 18K | $18.00 | $330K |
| Sep 27, 2024 | Healy James | Director | Buy(P) | 22K | $18.00 | $393K |
| Sep 27, 2024 | Healy James | Director | Buy(P) | 11K | $18.00 | $200K |
| Sep 27, 2024 | Healy James | Director | Conversion(C) | 7.3M | — | — |
| Sep 27, 2024 | Enright Patrick G | Director | Conversion(C) | 1.3M | — | — |
| Sep 27, 2024 | Enright Patrick G | Director | Buy(P) | 400K | $18.00 | $7.2M |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).